Mar 8
|
HIGHLIGHTS-Novo Nordisk hopes to launch experimental obesity drug this decade
|
Mar 7
|
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment
|
Jan 14
|
These 9 Stocks Are Running To Start 2024
|
Jan 4
|
Catalent, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
Dec 19
|
Catalent Announces Closing of Incremental Term Loans
|
Sep 28
|
Catalent (CTLT) Down 6.5% Since Last Earnings Report: Can It Rebound?
|
Sep 27
|
3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio
|
Sep 11
|
Is Catalent Inc (CTLT) Set to Underperform? Analyzing the Factors Limiting Growth
|
Sep 11
|
Is Catalent (CTLT) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
|
Sep 7
|
Catalent, Inc. to Present at September Investor Conferences
|
Aug 25
|
Unmasking the Potential Value Trap: A Comprehensive Analysis of Catalent Inc
|
Aug 24
|
Catalent (CTLT) to Report Q4 Earnings: What's in the Cards?
|
Aug 24
|
Catalent (CTLT) Declined on Disappointing Execution
|
Aug 23
|
REFILE-Novo hires Thermo Fisher as 2nd manufacturer for Wegovy weight-loss drug - source
|
Aug 22
|
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2023 Earnings Conference Webcast
|
Jul 23
|
4 hot insider trades & hedge fund hits: Cathie Wood writes down Twitter stake
|
Jul 20
|
Catalent stock jumps on report of activist investor Elliott taking stake
|
Jul 20
|
Activist investor Elliott takes stake in drug manufacturer Catalent - source
|
Jul 19
|
Elliott Takes Big Stake in Drugmaker Catalent
|
Jul 19
|
Activist investor Elliott takes big stake in drugmaker Catalent - WSJ
|